{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-004251","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.805478+00:00","generated_at":"2026-06-04T06:10:49.460176+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Helius Medical Q4 revenue down 52% YoY; net loss per share $1.47 vs $8.66","bullets":["Q4 2023 revenue $134K, down from $282K in Q4 2022, due to US PTAP expiration and lower Canada sales.","Net loss $1.0M in Q4 2023 vs $4.9M in Q4 2022; basic EPS loss $1.47 vs $8.66.","FY2023 revenue $644K vs $787K; net loss $8.9M vs $14.1M; operating loss $12.4M vs $15.5M.","Cash $5.2M at Dec 31, 2023; raised $1.3M in Q1 2024 ATM at avg $9.27/share, runway to Q3 2024.","CMS assigned HCPCS codes for PoNS mouthpiece/controller effective Apr 1, 2024; targeting Medicare reimbursement by Oct 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-004251","json":"https://secwatch.observer/filing/0001558370-24-004251.json","markdown":"https://secwatch.observer/filing/0001558370-24-004251.md","text":"https://secwatch.observer/filing/0001558370-24-004251.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/0001558370-24-004251-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/hsdt-20240328x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:10:49.460176+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eafd75ed53d4205b1e398d775f0aaf496d12d209","claim":"Solana Co reported financial results for the quarter and full year ended December 31, 2023.","evidence_excerpt":"On March 28, 2024, Helius Medical Technologies, Inc. (the “Registrant”) issued a press release announcing its financial results for the quarter and year ended December 31, 2023, as well as information regarding a conference call to discuss these financial results and the Registrant’s recent corporate highlights.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/0001558370-24-004251-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and full year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}